Screening and diagnosis

Classification and risk stratification

Perioperative care

Quality improvement

Patient education

Nonpharmacologic interventions

Therapeutic procedures

Respiratory support

Follow-up and surveillance

Specific circumstances

Preventative measures

Medical management

Surgical interventions

Inpatient care

Diagnostic procedures

Diagnostic investigations

Insufficient evidence to make a recommendation.

Strongly favor this test or intervention.

The TNM classification calculator evaluates duodenal neuroendocrine tumors by assessing three critical parameters: the tumor classification, the lymph node involvement, and the presence of distant metastasis. Each category offers specific options corresponding to the tumor's characteristics, spreading potential, and metastasis involvement.

Input categories and their classifications:

1. Tumor Classification:
   - Tx: The primary tumor cannot be assessed
   - T0: No evidence of the primary tumor
   - T1: The tumor is 1 cm or smaller and invades only the mucosa or submucosa; applicable to ampullary tumors confined within the sphincter of Oddi
   - T2: The tumor exceeds 1 cm or invades the muscularis propria for duodenal tumors
   - T3: The tumor invades the pancreas or peripancreatic adipose tissue
   - T4: The tumor invades visceral peritoneum or other organs

2. Lymph Node Classification:
   - Nx: Regional lymph nodes cannot be assessed
   - N0: No regional lymph node metastasis
   - N1: Regional lymph nodes present with metastases

3. Distant Metastasis:
   - M0: No distant metastasis detected
   - M1a: Metastasis is confined to the liver
   - M1b: Metastases present at one or more extrahepatic sites, such as the lung, ovary, non-regional lymph nodes, peritoneum, and bone
   - M1c: Metastases present in both hepatic and extrahepatic sites

The interpretation of this data is performed via logical conditions that match specific combinations of the tumor classification, lymph node classification, and the presence or absence of distant metastasis, resulting in a stage designation according to the complexity and spread of the tumor.

Key logic-based determinations used in the computation:

- If a tumor is classified as T1, with no regional lymph node involvement (N0) and no distant metastasis (M0), the tumor stage is deemed Stage I.
- Tumors classified as T2 or T3, absent regional lymph node metastasis (N0), and absent distant metastasis (M0), are assigned Stage II.
- Stage III status occurs if there is either a T4 classification with no regional lymph node metastasis (N0) and absence of distant metastasis (M0), or any T classification with regional lymph node metastases (N1) and no distant metastasis (M0).
- Stage IV encompasses any tumor classification (T1 to T4) with either regional lymph node presence (N0 or N1) and any distant metastasis classification (M1a, M1b, or M1c).

The TNM classification for duodenal neuroendocrine tumors is a clinical staging system developed by the American Joint Committee on Cancer (AJCC). This system is designed for the stratification of patients with duodenal neuroendocrine tumors based on the extent of the disease, which aids in guiding treatment decisions and predicting prognosis.

The primary components of this classification system include the size and extent of the primary tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). Each of these components is assigned a numerical value based on the severity or extent of the disease. The T category is determined by the size of the primary tumor and its extent of invasion into the duodenal wall. The N category is determined by the number and location of regional lymph nodes involved. The M category is determined by the presence or absence of distant metastasis.

The final TNM stage is determined by combining the T, N, and M categories. This stage provides a comprehensive assessment of the disease extent and is crucial in determining the most appropriate treatment strategy and predicting patient prognosis. The TNM classification for duodenal neuroendocrine tumors is a valuable tool in the clinical management of patients with this disease.

TNM classification for duodenal neuroendocrine tumors

The TNM classification system for jejunoileal neuroendocrine tumors uses three key classifications to determine the stage of the tumor: tumor classification, lymph node classification, and distant metastasis. Users provide their selections among specific predefined options for each category. Based on these selections, the system computes the tumor stage using established criteria.

For tumor classification, the options include:

- Tx: Primary tumor cannot be assessed
- T0: No evidence of primary tumor
- T1: Tumor less than or equal to 1 cm and invades lamina propria or submucosa
- T2: Tumor greater than 1 cm or invades muscularis propria
- T3: Tumor invades through muscularis propria into subserosal tissue without penetration of the overlying serosa
- T4: Tumor invades visceral peritoneum or other organs or adjacent structures

Lymph node assessment options are:

- Nx: Regional lymph nodes cannot be assessed
- N0: No regional lymph node metastasis
- N1: Regional lymph node metastases in fewer than 12 nodes
- N2: Large mesenteric masses (more than 2 cm) and/or extensive nodal deposits (12 or more), especially encasing superior mesenteric vessels

Finally, distant metastasis options include:

- M0: No distant metastasis
- M1a: Metastasis confined to the liver
- M1b: Metastases in one or more extrahepatic sites, such as the lung, ovary, nonregional lymph node, peritoneum, and bone
- M1c: Metastases in both hepatic and extrahepatic sites

The system then applies a logic to map combinations of these selections to specific cancer stages:

- Stage I is identified when the selections are T1, N0, and M0.
- Stage II is determined by T2 or T3, combined with N0 and M0.
- Stage III encapsulates conditions where selections meet one of these patterns:
  - Tumor classifications T1, T2, or T3 with lymph node classifications N1 or N2, and M0.
  - A tumor classified as T4 with any lymph node classification and M0.
- Stage IV is assigned when any tumor classification (T1 through T4) with any lymph node classification and distant metastasis (M1a, M1b, or M1c) are selected.

Using these combinations, the TNM classification system effectively interprets and provides a stage designation for jejunoileal neuroendocrine tumors, guiding clinical decision-making by carefully considering tumor size, location, lymph node involvement, and metastasis status.

The TNM classification for jejunoileal neuroendocrine tumors is a clinical staging system developed by the American Joint Committee on Cancer (AJCC). It is designed to stratify patients with jejunoileal neuroendocrine tumors based on the extent of the disease, which aids in guiding treatment decisions and predicting prognosis. 

The primary components of this classification system include the size and extent of the primary tumor (T), the presence and extent of regional lymph node involvement (N), and the presence of distant metastasis (M). Each of these components is assigned a numerical value, with higher values indicating more advanced disease. 

The T category is determined by the size of the primary tumor and its extent of invasion into the surrounding tissues. The N category is determined by the number and location of regional lymph nodes involved. The M category is determined by the presence or absence of distant metastasis. 

The final TNM stage is determined by combining the T, N, and M categories. This stage provides a comprehensive picture of the patient's disease status and is used to guide treatment decisions and predict prognosis. 

Exclusion criteria for this classification system include patients with neuroendocrine tumors of other gastrointestinal sites, as the TNM classification for jejunoileal neuroendocrine tumors is specific to tumors originating in the jejunum and ileum.

Small bowel neuroendocrine tumors

Guidelines

Key sources

Diagnostic investigations

Diagnostic procedures

Medical management

Surgical interventions

Specific circumstances